Related Experiment Video
Updated: Oct 4, 2025

09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
648
Anti-PD-1 for pretreated advanced anal carcinoma: which patients will benefit?
1Department of Gastroenterology, Pontchaillou University Hospital, Rennes University, INSERM U1242, Rennes, France.
The Lancet. Gastroenterology & Hepatology
|February 3, 2022
Abstract
No abstract available in PubMed .

